MedPath

Evaluation of the Effectiveness of Solution-Focused Brief group Therapy on reducing Anxiety and Depression.

Not Applicable
Recruiting
Conditions
Condition 1: Depression. Condition 2: Anxiety.
Major depressive disorder, single episode
Anxiety disorder due to known Physiological condition
F06.4
Registration Number
IRCT20220706055395N1
Lead Sponsor
Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with Anxiety and Depression Disorders admitted to the Psychiatric Ward
Patients 18 to 60 years old

Exclusion Criteria

Psychotic or Mania Patients
Patients with Personality Disorders
Substance Abuse Patients
Mentally Retarded Patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The Percentage of People who Score higher than 21 in the Depression Subscale of the DASS-21 Questionnaire. Timepoint: Depression in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Depression is measured by the Depression Subscale of the Depression- Anxiety- Stress Scale(DASS-21) Questionnaire.;The Percentage of People who Score higher than 15 in the Anxiety-Stress Subscale of the DASS-21 Questionnaire. Timepoint: Anxiety in the intervention Group is measured at the beginning of Hospitalization (before the intervention) and after the intervention (after three weeks). In the Control group, it is measured from the beginning of Hospitalization and after three Weeks. Method of measurement: Anxiety is measured by the Anxiety Subscale of the DASS-21 qQuestionnaire.
Secondary Outcome Measures
NameTimeMethod
. Timepoint: . Method of measurement: .
© Copyright 2025. All Rights Reserved by MedPath